您当前的位置：
首页 >
文章列表页 >
Activation of Nrf2/HO-1/NQO1 Signaling Pathway by Shenqi Tangluo Pill Improves Oxidative Stress Injury of Skeletal Muscle of Type 2 Diabetes Mellitus Mice
更新时间：2024-03-04

    • Activation of Nrf2/HO-1/NQO1 Signaling Pathway by Shenqi Tangluo Pill Improves Oxidative Stress Injury of Skeletal Muscle of Type 2 Diabetes Mellitus Mice

    • “The latest research found that Shenqitangluo Pill significantly improved the oxidative stress injury of skeletal muscle in type 2 diabetes mice by activating Nrf2/HO-1/NQO1 pathway.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 7, Pages: 131-139(2024)

    • DOI：10.13422/j.cnki.syfjx.20232138    

      CLC： R2-0;R33;R289;R587.1

    • Received：31 August 2023，

      Published Online：22 December 2023，

      Published：05 April 2024

    移动端阅览

  • PEI Xiaoli,LIANG Yonglin,⁎ ,et al.Activation of Nrf2/HO-1/NQO1 Signaling Pathway by Shenqi Tangluo Pill Improves Oxidative Stress Injury of Skeletal Muscle of Type 2 Diabetes Mellitus Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(07):131-139. DOI： 10.13422/j.cnki.syfjx.20232138.

  •  
  •  

0

Views

53

下载量

2

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Renal Protective Mechanism of Danggui Shaoyaosan in db/db Mice Based on RhoA/ROCK/NF-κB Signaling Pathway
Mechanisms of Traditional Chinese Medicine in Treatment of Traumatic Optic Neuropathy： A Review
Mechanistic Study on Combined Application of Arsenic Trioxide and Its Dimethylarsinic Acid Metabolite in Promoting Apoptosis of Acute Promyelocytic Leukemia NB4 Cells
Mechanism of Yitangkang Prescription in Improving Metabolic-inflammatory Imbalance in Diabetic Kidney Disease by Cross-organ Regulation of Mast Cell Network

Related Author

⁎
DUAN Yongqiang
⁎
ZHU Xiangdong
HOU Luyu
ZHANG Yuanyuan
SHI Wenjing
GUO Shilong

Related Institution

Key Laboratory of Ministry of Education of TCM Prevention and Treatment of High-Incidence Diseases in Ningxia
Graduate School， Hebei University of Chinese Medicine
The Third Hospital of Hebei Medical University
The First Affiliated Hospital of Hebei University of Chinese Medicine
Hebei Provincial Technology Innovation Center for Traditional Chinese Medicine Spleen and Kidney Diseases
0